Air Products and Chemicals, Inc. is an industrial gases company. The company has market cap of $30.79 billion. The Company’s Industrial Gases business provides atmospheric and process gases and related equipment to manufacturing markets, including refining and petrochemical, metals, electronics, and food and beverage. It has a 23.7 P/E ratio. The Firm operates through seven divisions: Industrial Gases-Americas, Industrial Gases-Europe, Middle East, and Africa , Industrial Gases-Asia, Industrial Gases-Global, Materials Technologies, Energy-from-Waste, and Corporate and other.
The stock decreased 2.38% or $4 during the last trading session, reaching $163.73. About shares traded. IDEXX Laboratories, Inc. (NDAQ:IDXX) has risen 47.03% since September 23, 2016 and is uptrending. It has outperformed by 36.70% the S&P500.
Pershing Square Capital Management L.P. holds 9.41% of its portfolio in Air Products & Chemicals, Inc. for 3.87 million shares. Freshford Capital Management Llc owns 195,006 shares or 9.16% of their US portfolio. Moreover, Glenhill Advisors Llc has 7.12% invested in the company for 698,736 shares. The Pennsylvania-based Mycio Wealth Partners Llc has invested 5.78% in the stock. Banbury Partners Llc, a North Carolina-based fund reported 118,900 shares.
Ratings analysis reveals 53% of Air Products & Chemicals’s analysts are positive. Out of 15 Wall Street analysts rating Air Products & Chemicals, 8 give it “Buy”, 1 “Sell” rating, while 6 recommend “Hold”. The lowest target is $16 while the high is $167. The stock’s average target of $141.64 is -0.27% below today’s ($142.03) share price. APD was included in 28 notes of analysts from August 4, 2015. On Monday, December 5 the stock rating was upgraded by Citigroup to “Buy”. Global Hunter Securities upgraded Air Products & Chemicals, Inc. (NYSE:APD) rating on Tuesday, August 4. Global Hunter Securities has “” rating and $165 target. On Thursday, October 8 the stock rating was upgraded by Goldman Sachs to “Buy”. The firm earned “Buy” rating on Monday, November 21 by Argus Research. On Friday, July 31 the stock rating was maintained by Deutsche Bank with “Buy”. The stock of Air Products & Chemicals, Inc. (NYSE:APD) earned “Neutral” rating by Citigroup on Friday, July 15. Susquehanna maintained the stock with “Neutral” rating in Wednesday, October 7 report. The rating was downgraded by Robert W. Baird to “Neutral” on Monday, January 30. Credit Suisse reinitiated Air Products & Chemicals, Inc. (NYSE:APD) on Thursday, March 24 with “Outperform” rating. Zacks upgraded the stock to “Hold” rating in Monday, August 24 report.
The stock increased 1.09% or $1.53 during the last trading session, reaching $142.03. About shares traded. Air Products & Chemicals, Inc. (NYSE:APD) has risen 4.12% since September 23, 2016 and is uptrending. It has underperformed by 6.21% the S&P500.
Since November 8, 2016, it had 1 insider purchase, and 10 insider sales for $22.63 million activity. 36,250 shares were sold by AYERS JONATHAN W, worth $5.13 million. Another trade for 8,500 shares valued at $1.02 million was made by CRAIG THOMAS on Wednesday, November 23. HENDERSON REBECCA M also sold $943,721 worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) shares. END WILLIAM T sold $549,359 worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) on Tuesday, November 8. JUNIUS DANIEL M had sold 3,000 shares worth $425,264. 1,000 shares were bought by Kingsley Lawrence D, worth $146,480 on Wednesday, March 1. $1.41 million worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) was sold by MCKEON BRIAN P on Wednesday, February 8.
Investors sentiment decreased to 0.93 in 2016 Q4. Its down 0.21, from 1.14 in 2016Q3. It fall, as 29 investors sold IDEXX Laboratories, Inc. shares while 183 reduced holdings. 67 funds opened positions while 130 raised stakes. 75.18 million shares or 3.36% less from 77.79 million shares in 2016Q3 were reported. Weiss Multi invested in 0.04% or 7,251 shares. The Pennsylvania-based Conestoga Cap Ltd Limited Liability Company has invested 0.02% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Bbva Compass Bank & Trust accumulated 2,846 shares or 0.02% of the stock. Guggenheim Ltd Liability accumulated 118,234 shares. Paloma Partners Mngmt reported 19,574 shares. Seaward Mngmt Lp has 0.1% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Moreover, Lazard Asset Mngmt Llc has 0.03% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Bridgeway Cap Management Inc reported 0.08% stake. Fiduciary Tru has 0.11% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 30,027 shares. Ledyard National Bank & Trust invested in 1,859 shares or 0.04% of the stock. Ims Mngmt holds 0.89% or 7,110 shares in its portfolio. Northwestern Mutual Wealth Management owns 577 shares or 0% of their US portfolio. 2.27M are owned by Neuberger Berman Limited Liability. Finemark Comml Bank & Tru reported 0% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Friedberg Inv Mngmt stated it has 1.5% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX).
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. The company has market cap of $14.84 billion. The Firm also sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. It has a 66.91 P/E ratio. The Company’s divisions include diagnostic and information technology services and products for the veterinary market, which the Company refers to as the Companion Animal Group; water quality products; diagnostic services and products for livestock and poultry health, which the Company refers to as Livestock, Poultry and Dairy, and Other operating segment, which combines and presents products for the human point-of-care medical diagnostics market with its pharmaceutical product line and its out-licensing arrangements.
